Katherine Esposito

38.3k total citations · 12 hit papers
325 papers, 26.0k citations indexed

About

Katherine Esposito is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Katherine Esposito has authored 325 papers receiving a total of 26.0k indexed citations (citations by other indexed papers that have themselves been cited), including 213 papers in Endocrinology, Diabetes and Metabolism, 62 papers in Molecular Biology and 61 papers in Surgery. Recurrent topics in Katherine Esposito's work include Diabetes Treatment and Management (90 papers), Diabetes Management and Research (76 papers) and Metabolism, Diabetes, and Cancer (45 papers). Katherine Esposito is often cited by papers focused on Diabetes Treatment and Management (90 papers), Diabetes Management and Research (76 papers) and Metabolism, Diabetes, and Cancer (45 papers). Katherine Esposito collaborates with scholars based in Italy, Spain and United States. Katherine Esposito's co-authors include Dario Giugliano, Raffaele Marfella, Maria Ida Maiorino, Antonio Ceriello, Giovanni Giugliano, Giuseppe Bellastella, Francesco Giugliano, Paolo Chiodini, Carmen Di Palo and Francesco Nappo and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Katherine Esposito

318 papers receiving 25.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans

2002 1.6k citations Katherine Esposito, Francesco Giugliano et al. Circulation profile →
Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome

2004 1.6k citations Katherine Esposito, Miryam Ciotola et al. profile →
Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women

2003 1.2k citations Katherine Esposito, Alessandro Pontillo et al. profile →
Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients

2008 987 citations Antonio Ceriello, Katherine Esposito et al. Diabetes profile →
Metabolic Syndrome and Risk of Cancer

2012 914 citations Katherine Esposito, Paolo Chiodini et al. Diabetes Care profile →
The Effect of Mediterranean Diet on Metabolic Syndrome and its Components

2011 777 citations Katherine Esposito, Dario Giugliano et al. profile →
Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year

2002 775 citations Katherine Esposito, Dario Giugliano et al. Circulation profile →
The Effects of Diet on Inflammation

2006 638 citations Dario Giugliano, Antonio Ceriello et al. profile →
Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men

2004 569 citations Katherine Esposito, Francesco Giugliano et al. profile →
A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses

2015 316 citations Katherine Esposito, Maria Ida Maiorino et al. profile →
Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials

2020 227 citations Maria Ida Maiorino, Antonietta Maio et al. Diabetes Care profile →
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

2022 101 citations Dario Giugliano, Miriam Longo et al. Cardiovascular Diabetology profile →

Peers

Countries citing papers authored by Katherine Esposito

Since Specialization

Citations

This map shows the geographic impact of Katherine Esposito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Esposito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Esposito more than expected).

Fields of papers citing papers by Katherine Esposito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Esposito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Esposito. The network helps show where Katherine Esposito may publish in the future.

Co-authorship network of co-authors of Katherine Esposito

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Esposito. A scholar is included among the top collaborators of Katherine Esposito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Esposito. Katherine Esposito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Glycemia Risk Index (GRI) as a Biomarker for Subclinical Endothelial Dysfunction in Type 1 Diabetes: A Cross-Sectional Study 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), Antonietta Maio, Paolo Cirillo, Alessandro Pontillo, Mariangela Caputo, Lorenzo Scappaticcio, Paola Caruso, Miriam Longo, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito	0
2	Glucagon‐like peptide 1 receptor agonist for peripheral artery disease: Is it time to proceed? 2025 ·Diabetes Obesity and Metabolism ·Dario Giugliano, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito	0
3	Two years with GIOIA ‘Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes’: A prospective, multicentre, quasi‐experimental study on sodium‐glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors in diabetes clinical practice 2024 ·Diabetes Obesity and Metabolism ·Miriam Longo, Paola Caruso, Lorenzo Scappaticcio, Maria Ida Maiorino, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano	2
4	Psychometric properties of health-related quality of life instruments used in survivors of critical illness: a systematic review 2023 ·Quality of Life Research ·(unknown), (unknown), Katherine Esposito, Alisa M. Higgins, Carol Hodgson	4
5	BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes 2023 ·Endocrine ·Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Paola Caruso, Maurizio Gicchino, Michela Petrizzo, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito	3
6	European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 2022 ·Pharmaceuticals ·Gabriella di Mauro, Annamaria Mascolo, Miriam Longo, Maria Ida Maiorino, Lorenzo Scappaticcio, Giuseppe Bellastella, Katherine Esposito, Annalisa Capuano	10
7	Exploring the Performance of Ultrasound Risk Stratification Systems in Thyroid Nodules of Pediatric Patients 2021 ·Cancers ·Lorenzo Scappaticcio, Maria Ida Maiorino, Sergio Iorio, Giovanni Docimo, Miriam Longo, Anna Grandone, (unknown), Immacolata Cozzolino, Arnoldo Piccardo, Pierpaolo Trimboli, Emanuele Miraglia del Giudice, Katherine Esposito, Giuseppe Bellastella	28
8	GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off 2021 ·Cardiovascular Diabetology ·Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, Giuseppe Bellastella, Katherine Esposito	28
9	Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial 2021 ·Diabetes Care ·Dario Giugliano, Miriam Longo, Paola Caruso, (unknown), Lorenzo Scappaticcio, Maurizio Gicchino, Michela Petrizzo, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito	34
10	Alterations in the Levels of Circulating and Endothelial Progenitor Cells Levels in Young Adults with Type 1 Diabetes: A 2-Year Follow-Up from the Observational METRO Study 2020 ·SHILAP Revista de lepidopterología ·Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Vincenzo Pernice, Paolo Cirillo, Antonio De Maio, (unknown), Dario Giugliano, Katherine Esposito, (unknown)	0
11	Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta‐analysis with meta‐regression 2020 ·Diabetes Obesity and Metabolism ·Dario Giugliano, Giuseppe Bellastella, Miriam Longo, Lorenzo Scappaticcio, Maria Ida Maiorino, Paolo Chiodini, Katherine Esposito	29
12	Class effect for SGLT-2 inhibitors: a tale of 9 drugs 2019 ·Cardiovascular Diabetology ·Dario Giugliano, Katherine Esposito	33
13	GLP‐1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis including the REWIND and PIONEER 6 trials 2019 ·Diabetes Obesity and Metabolism ·Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Miriam Longo, Paolo Chiodini, Katherine Esposito	96
14	Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope 2019 ·Diabetes Obesity and Metabolism ·Dario Giugliano, Juris J. Meier, Katherine Esposito	38
15	More sugar? No, thank you! The elusive nature of low carbohydrate diets 2018 ·Endocrine ·Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito	18
16	Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes 2012 ·Diabetes ·Antonio Ceriello, Anna Novials, (unknown), Lucia La Sala, Gemma Pujadas, Roberto Testa, Anna Rita Bonfigli, Katherine Esposito, Dario Giugliano	124
17	Hyperlipidemia and Sexual Function in Premenopausal Women 2009 ·The Journal of Sexual Medicine ·Katherine Esposito, Miryam Ciotola, Maria Ida Maiorino, Francesco Giugliano, Riccardo Autorino, Marco De Sio, Domenico Cozzolino, F. Saccomanno, Dario Giugliano	47
18	Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients 2005 ·Circulation ·Antonio Ceriello, Roberta Assaloni, Roberto Da Ros, (unknown), Ludovica Piconi, Lisa Quagliaro, Katherine Esposito, Dario Giugliano	238
19	Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans 2004 ·European Journal of Endocrinology ·A. E. Pontiroli, P. Pizzocri, (unknown), Paola Vedani, M. Marchi, Cinzia Arcelloni, Rita Paroni, Katherine Esposito, Dario Giugliano	72
20	Weight Loss Reduces Interleukin-18 Levels in Obese Women 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Katherine Esposito, Alessandro Pontillo, (unknown), Carmen Di Palo, Elisa Grella, Gianfranco Nicoletti, Dario Giugliano	208

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact